If the Drug Doesn't Work, You Don't Pay: The Reality of Outcomes-Based Contracting
/
Latest idea to reduce drug costs is a wolf in sheep's clothing.
Read More
Rising Cost of Healthcare in US Driven By Rising Prices in Absence of Rising Demand
/
A new study finds that the main driver of rising health costs in the US is the prices of goods and services. But prices are rising as demand is decreasing.
Read MoreWhat the Market Will Bear: Doc-to-Doc on Skyrocketing Drug Prices with Dr. Umesh Khot
/
Dr. Umesh Khot is the Vice-Chairman of the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at the Cleveland Clinic and the author of a research letter in the New England Journal of Medicine examining the effects of the astronomical price increases of isoproteronol and nitroprusside. In this doc-to-doc interview, Dr. Khot discusses the reasons the prices increased, the effects that had on utilization of the drugs, and the implications this has more broadly in our healthcare system.
Read MoreOne Weird Trick that Would Get Epipen Fully Covered By Insurance
/
Mylan pharmaceuticals is lobbying the United States Preventive Services Task Force to label Epipen as a "preventive" medication, which would effectively transfer the exorbitant cost from individuals to insurance companies. This is not the right strategy, folks. For the video version, click here.
Read More